🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Patient therapy is tailored according to the molecular profile of the patie...
Status
Completed
Location
Georgetown University- Lombardi Comprehensive Cancer Center
Start Date
2012-12
Trial ID
NCT01888978
The Double-T trial is a prospective, randomized, single-arm, open-label, mu...
Status
Not Yet Recruiting
Location
Universitätsklinikum Heidelberg - Innere Medizin V
Start Date
2026-04
Trial ID
NCT07542678
To determine the primary end point response rate of the combinations of Gem...
Status
Completed
Location
Hematology Oncology Associates
Start Date
2005-10
Trial ID
NCT00250822
Treatments Being Tested
In patients with relapsed or refractory diffuse DLBCL who have not achieved...
Status
Active Not Recruiting
Location
Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, beijing,
Start Date
2026-01-01
Trial ID
NCT07480850
Treatments Being Tested
The main research objective is to work out the optimal doses of the novel c...
Status
Completed
Location
Royal Marsden NHS Foundation Trust
Start Date
2006-07
Trial ID
NCT01048320
Treatments Being Tested
This is a single arm phase II trial of Gemcitabine and Oxaliplatin (Gem-Ox)...
Status
Terminated
Location
California Pacific Medical Center
Start Date
2007-08
Trial ID
NCT00832637
Treatments Being Tested
This randomized phase II trial will compare the efficacy and toxicity of Ge...
Status
Terminated
Location
University General Hospital of Alexandroupolis, Department of Medical Oncology
Start Date
2006-12
Trial ID
NCT00564720
Treatments Being Tested
The purpose of this study is to evaluate the safety and tolerability of MT-...
Status
Terminated
Location
UC Irvine Health / Chao Family Comprehensive Cancer Center
Start Date
2018-08-20
Trial ID
NCT03488251
Treatments Being Tested